Protagonist Therapeutics Reports Granting of Inducement Award

NEWARK, Calif., Dec. 1, 2020 /PRNewswire/ --Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on November 30, 2020, it issued an inducement award to Michelle Landolfi, Ph.D., the Company's recently hired Vice President, Regulatory Affairs, in accordance with the terms of Dr. Landolfi's employment offer letter.